SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001493152-24-035256
Filing Date
2024-09-06
Accepted
2024-09-06 14:04:41
Documents
2
Group Members
GOODWOOD FUNDPETER PUCCETTI

Document Format Files

Seq Description Document Type Size
1 formsc13d.htm SC 13D 118324
2 ex99-1.htm EX-99.1 11785
  Complete submission text file 0001493152-24-035256.txt   131991
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
COSCIENS Biopharma Inc. (Subject) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-51184 | Film No.: 241283955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 212 KING STREET WEST SUITE 201 TORONTO A6 M5H1K5
Business Address 212 KING STREET WEST SUITE 201 TORONTO A6 M5H1K5 416-203-2022
Goodwood Inc. (Filed by) CIK: 0001297339 (see all company filings)

IRS No.: 000000000
Type: SC 13D